The Net Margin of China Biologic Products Holdings Inc (CBPO) is
29.04%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date |
Value |
| 2020-12-31 |
29.04%
|
| 2019-12-31 |
27.56%
|
| 2018-12-31 |
27.43%
|
| 2017-12-31 |
18.34%
|
| 2016-12-31 |
30.71%
|
| 2015-12-31 |
30.04%
|
| 2014-12-31 |
29.15%
|
| 2013-12-31 |
26.84%
|
| 2012-12-31 |
24.46%
|
| 2011-12-31 |
11.89%
|
| Ticker |
Name |
Value |
|
300122.SZ
|
Chongqing Zhifei Biological Products Co Ltd
|
-164.35%
|
|
300142.SZ
|
Walvax Biotechnology Co Ltd
|
7.35%
|
|
ARWR
|
Arrowhead Pharmaceuticals, Inc.
|
-160.64%
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
30.16%
|
|
INSM
|
Insmed Incorporated
|
-210.54%
|
|
MYGN
|
Myriad Genetics, Inc.
|
-44.38%
|
|
ORGO
|
Organogenesis Holdings Inc.
|
6.56%
|
|
6160.HK
|
Beigene Ltd
|
-517.01%
|
|
AMRN
|
Amarin Corporation PLC
|
-18.16%
|
|
CHRS
|
Coherus Oncology Inc
|
398.43%
|
|
MDXG
|
MiMedx Group, Inc.
|
11.60%
|
|
XNCR
|
Xencor, Inc.
|
-73.20%
|
|
300601.SZ
|
Shenzhen Kangtai Biological Products Co Ltd
|
2.63%
|
|
688363.SS
|
Bloomage Biotechnology Corp Ltd
|
6.96%
|
|
SRRK
|
Scholar Rock Holding Corporation
|
-405.21%
|
|
TWST
|
Twist Bioscience Corporation
|
-28.34%
|
|
1801.HK
|
Innovent Biologics Inc
|
6.24%
|
|
603392.SS
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
|
-21.90%
|
|
HRTX
|
Heron Therapeutics Inc
|
-13.04%
|
|
PGEN
|
Precigen, Inc.
|
-2588.21%
|
|
EXEL
|
Exelixis Inc
|
33.73%
|
|
MORF
|
Morphic Holding Inc
|
-29192.90%
|
|
PTCT
|
PTC Therapeutics, Inc.
|
39.44%
|
|
VCEL
|
Vericel Corporation
|
5.98%
|
|
ZNTL
|
Zentalis Pharmaceuticals, Inc.
|
-245.96%
|
|
ACAD
|
Acadia Pharmaceuticals Inc.
|
36.49%
|
|
TVTX
|
Travere Therapeutics, Inc.
|
-5.21%
|
|
VIR
|
Vir Biotechnology, Inc.
|
-638.87%
|
|
002007.SZ
|
Hualan Biological Engineering Inc
|
20.47%
|
|
300896.SZ
|
Imeik Technology Development Co Ltd
|
52.64%
|
|
9688.HK
|
Zai Lab Ltd
|
-38.15%
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
-764.01%
|
|
EDIT
|
Editas Medicine, Inc.
|
-395.01%
|
|
MDGL
|
Madrigal Pharmaceuticals, Inc.
|
-30.08%
|
|
SRNE
|
Sorrento Therapeutics Inc
|
-912.10%
|
|
ENTA
|
Enanta Pharmaceuticals Inc
|
-125.36%
|
|
MGNX
|
MacroGenics Inc
|
-49.91%
|